Free Trial

Mesabi Trust (MSB) Financials

Mesabi Trust logo
$30.87 -0.32 (-1.03%)
Closing price 03:59 PM Eastern
Extended Trading
$30.86 -0.01 (-0.02%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Mesabi Trust

Annual Income Statements for Mesabi Trust

This table shows Mesabi Trust's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 1/31/2022 1/31/2023 1/31/2024 1/31/2025
Net Income / (Loss) Attributable to Common Shareholders
69 5.31 19 93
Consolidated Net Income / (Loss)
69 5.31 19 93
Net Income / (Loss) Continuing Operations
69 5.31 19 93
Total Pre-Tax Income
69 5.31 19 93
Total Operating Income
69 5.31 19 93
Total Gross Profit
71 7.35 23 98
Total Revenue
71 7.74 23 99
Operating Revenue
71 7.74 23 99
Total Cost of Revenue
0.35 0.39 0.32 0.32
Operating Cost of Revenue
0.29 0.33 0.26 0.26
Other Cost of Revenue
0.06 0.06 0.06 0.06
Total Operating Expenses
2.34 2.04 3.56 5.00
Selling, General & Admin Expense
0.05 0.05 0.33 0.50
Other Operating Expenses / (Income)
0.56 0.61 0.66 0.65
Other Special Charges / (Income)
1.73 1.37 2.57 3.85
Total Other Income / (Expense), net
0.00 0.00 0.00 0.00
Basic Earnings per Share
$5.24 $0.41 $1.45 $7.11
Weighted Average Basic Shares Outstanding
13.12M 13.12M 13.12M 13.12M
Weighted Average Diluted Shares Outstanding
13.12M 13.12M 13.12M 13.12M
Weighted Average Basic & Diluted Shares Outstanding
13.12M 13.12M 13.12M 13.12M

Quarterly Income Statements for Mesabi Trust

This table shows Mesabi Trust's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 7/31/2022 10/31/2022 1/31/2023 4/30/2023 7/31/2023 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-4.86 -0.41 -3.02 1.02 9.18 4.09 4.69 3.48 5.40 78 6.07
Consolidated Net Income / (Loss)
-4.86 -0.41 -3.02 1.02 9.18 4.09 4.69 3.48 5.40 78 6.07
Net Income / (Loss) Continuing Operations
-4.86 -0.41 -3.02 1.02 9.18 4.09 4.69 3.48 5.40 79 5.60
Total Pre-Tax Income
-4.86 -0.41 -3.02 1.02 9.18 4.09 4.69 3.48 5.40 79 5.60
Total Operating Income
-4.86 -0.41 -3.02 1.02 9.18 4.09 4.69 3.48 5.40 78 6.07
Total Gross Profit
-4.86 -0.41 -0.98 1.02 9.18 4.09 8.25 3.48 5.40 78 11
Total Revenue
-4.37 0.08 -2.17 1.85 9.89 4.90 6.23 6.25 6.49 79 6.85
Operating Revenue
-4.37 0.08 -2.17 1.85 9.89 4.90 6.23 6.25 6.49 79 6.85
Total Cost of Revenue
0.49 0.50 -1.20 0.83 0.71 0.81 -2.02 2.77 1.09 0.68 -4.22
Operating Cost of Revenue
0.49 0.50 -1.26 0.83 0.71 0.81 -2.08 2.77 1.09 0.68 -4.28
Total Operating Expenses
0.00 0.00 2.04 0.00 0.00 0.00 3.56 0.00 0.00 0.00 5.00
Total Other Income / (Expense), net
0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.47 -0.47
Basic Earnings per Share
($0.37) ($0.03) ($0.23) $0.08 $0.70 $0.31 $0.36 $0.27 $0.41 $5.97 $0.46
Weighted Average Basic Shares Outstanding
13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M
Weighted Average Diluted Shares Outstanding
13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M
Weighted Average Basic & Diluted Shares Outstanding
13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M

Annual Cash Flow Statements for Mesabi Trust

This table details how cash moves in and out of Mesabi Trust's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 1/31/2022 1/31/2023 1/31/2024 1/31/2025
Net Change in Cash & Equivalents
35 -34 10 76
Net Cash From Operating Activities
63 14 15 94
Net Cash From Continuing Operating Activities
63 14 15 94
Net Income / (Loss) Continuing Operations
69 5.31 19 93
Consolidated Net Income / (Loss)
69 5.31 19 93
Non-Cash Adjustments To Reconcile Net Income
-1.25 1.43 -0.45 0.21
Changes in Operating Assets and Liabilities, net
-4.67 7.12 -3.93 0.45
Net Cash From Investing Activities
9.91 0.00 0.00 0.00
Net Cash From Continuing Investing Activities
9.91 0.00 0.00 0.00
Net Cash From Financing Activities
-38 -48 -4.59 -18
Net Cash From Continuing Financing Activities
-38 -48 -4.59 -18
Payment of Dividends
-38 -48 -4.59 -18

Quarterly Cash Flow Statements for Mesabi Trust

This table details how cash moves in and out of Mesabi Trust's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 7/31/2022 10/31/2022 1/31/2023 4/30/2023 7/31/2023 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025
Net Change in Cash & Equivalents
-35 12 -0.54 -0.86 4.65 5.16 1.07 -2.35 0.00 74 4.29
Net Cash From Operating Activities
1.57 -0.26 -0.54 -0.86 4.65 5.16 5.66 2.50 3.81 78 9.41
Net Cash From Continuing Operating Activities
1.57 -0.26 -0.54 -0.86 4.65 5.16 5.66 2.50 3.81 78 9.41
Net Income / (Loss) Continuing Operations
-4.86 -0.41 -3.02 1.02 9.18 4.09 4.69 3.48 5.40 78 6.07
Consolidated Net Income / (Loss)
-4.86 -0.41 -3.02 1.02 9.18 4.09 4.69 3.48 5.40 78 6.07
Non-Cash Adjustments To Reconcile Net Income
4.40 - - 0.00 -2.03 1.03 0.55 -1.11 -0.18 1.07 0.43
Changes in Operating Assets and Liabilities, net
2.02 0.15 2.48 -1.89 -2.50 0.04 0.42 0.13 -1.41 -1.18 2.92
Net Cash From Financing Activities
-14 -11 - 0.00 - - -4.59 -4.85 -3.80 -3.94 -5.12
Net Cash From Continuing Financing Activities
-14 -11 - 0.00 - - -4.59 -4.85 -3.80 -3.94 -5.12
Payment of Dividends
-14 -11 - 0.00 - - -4.59 -4.85 -3.80 -3.94 -5.12

Annual Balance Sheets for Mesabi Trust

This table presents Mesabi Trust's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 1/31/2022 1/31/2023 1/31/2024 1/31/2025
Total Assets
54 14 27 102
Total Current Assets
54 14 27 102
Cash & Equivalents
48 14 24 100
Accounts Receivable
4.63 0.02 1.96 1.16
Prepaid Expenses
0.12 0.13 0.30 0.12
Plant, Property, & Equipment, net
0.00 0.00 0.00 0.00
Plant, Property & Equipment, gross
0.00 0.00 0.00 0.00
Total Noncurrent Assets
0.00 0.00 0.00 0.00
Total Liabilities & Shareholders' Equity
54 14 27 102
Total Liabilities
23 2.68 5.72 78
Total Current Liabilities
23 0.38 5.72 78
Accrued Expenses
0.16 0.38 0.86 0.34
Dividends Payable
23 0.00 4.85 78
Total Noncurrent Liabilities
0.00 2.30 0.00 0.00
Other Noncurrent Operating Liabilities
0.00 2.30 0.00 0.00
Total Equity & Noncontrolling Interests
31 11 21 23
Total Preferred & Common Equity
31 11 21 23
Total Common Equity
31 11 21 23
Other Equity Adjustments
31 11 21 23

Quarterly Balance Sheets for Mesabi Trust

This table presents Mesabi Trust's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 4/30/2022 7/31/2022 10/31/2022 4/30/2023 7/31/2023 10/31/2023 4/30/2024 7/31/2024 10/31/2024
Total Assets
45 26 15 15 22 26 25 26 101
Total Current Assets
45 26 15 15 22 26 25 26 101
Cash & Equivalents
38 2.45 15 13 18 23 22 22 96
Accounts Receivable
2.31 0.01 0.03 1.39 1.81 1.89 1.83 2.58 3.88
Prepaid Expenses
0.11 0.30 0.21 0.11 0.30 0.21 0.11 0.29 0.20
Plant, Property, & Equipment, net
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Plant, Property & Equipment, gross
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Noncurrent Assets
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Liabilities & Shareholders' Equity
45 26 15 15 22 26 25 26 101
Total Liabilities
14 11 0.30 2.14 0.26 4.87 4.48 4.13 5.34
Total Current Liabilities
14 11 0.30 0.22 0.26 4.87 4.48 4.13 5.34
Accrued Expenses
0.30 0.21 0.30 0.22 0.26 0.28 0.67 0.20 0.23
Dividends Payable
14 11 0.00 - - 4.59 3.80 3.94 5.12
Total Noncurrent Liabilities
0.00 0.00 0.00 1.93 0.00 0.00 0.00 0.00 0.00
Other Noncurrent Operating Liabilities
- 0.00 - 1.93 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
31 15 14 12 22 21 21 22 95
Total Preferred & Common Equity
31 15 14 12 22 21 21 22 95
Total Common Equity
31 15 14 12 22 21 21 22 95
Other Equity Adjustments
31 15 14 12 22 21 21 22 95

Annual Metrics And Ratios for Mesabi Trust

This table displays calculated financial ratios and metrics derived from Mesabi Trust's official financial filings.

Metric 2022 2023 2024 2025
Period end date 1/31/2022 1/31/2023 1/31/2024 1/31/2025
Growth Metrics
- - - -
Revenue Growth
175.37% -89.17% 195.30% 331.26%
EBITDA Growth
193.77% -92.28% 257.56% 391.35%
EBIT Growth
193.77% -92.28% 257.56% 391.35%
NOPAT Growth
193.77% -92.28% 257.56% 391.35%
Net Income Growth
193.77% -92.28% 257.56% 391.35%
EPS Growth
0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Growth
202.02% -77.94% 5.35% 543.14%
Free Cash Flow Firm Growth
202.02% -77.94% 8.61% 522.43%
Invested Capital Growth
5,659.93% -141.95% 155.26% -32.25%
Revenue Q/Q Growth
11.08% -72.22% 58.08% 0.64%
EBITDA Q/Q Growth
12.15% -79.40% 68.33% 1.50%
EBIT Q/Q Growth
12.15% -79.40% 68.33% 1.50%
NOPAT Q/Q Growth
12.15% -79.40% 68.33% 1.50%
Net Income Q/Q Growth
12.15% -79.40% 68.33% 1.50%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
16.22% -60.27% 73.71% 4.16%
Free Cash Flow Firm Q/Q Growth
16.22% -60.27% 60.02% 4.31%
Invested Capital Q/Q Growth
-33.64% -4,829.87% -23.06% -75.49%
Profitability Metrics
- - - -
Gross Margin
99.51% 94.90% 98.60% 99.68%
EBITDA Margin
96.23% 68.58% 83.03% 94.60%
Operating Margin
96.23% 68.58% 83.03% 94.60%
EBIT Margin
96.23% 68.58% 83.03% 94.60%
Profit (Net Income) Margin
96.23% 68.58% 83.03% 94.60%
Tax Burden Percent
100.00% 100.00% 100.00% 100.00%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
2,242.89% 303.47% 0.00% 7,959.21%
ROIC Less NNEP Spread (ROIC-NNEP)
2,242.89% 303.47% 0.00% 7,959.21%
Return on Net Nonoperating Assets (RNNOA)
-1,951.95% -278.32% 0.00% -7,538.13%
Return on Equity (ROE)
290.94% 25.14% 117.13% 421.08%
Cash Return on Invested Capital (CROIC)
2,049.72% 0.00% 1,077.71% 7,997.66%
Operating Return on Assets (OROA)
178.98% 15.61% 93.04% 145.27%
Return on Assets (ROA)
178.98% 15.61% 93.04% 145.27%
Return on Common Equity (ROCE)
290.94% 25.14% 117.13% 421.08%
Return on Equity Simple (ROE_SIMPLE)
223.30% 46.42% 90.50% 399.84%
Net Operating Profit after Tax (NOPAT)
69 5.31 19 93
NOPAT Margin
96.23% 68.58% 83.03% 94.60%
Net Nonoperating Expense Percent (NNEP)
0.00% 0.00% 0.00% 0.00%
Return On Investment Capital (ROIC_SIMPLE)
- - - 399.84%
Cost of Revenue to Revenue
0.49% 5.10% 1.40% 0.32%
SG&A Expenses to Revenue
0.07% 0.68% 1.44% 0.51%
R&D to Revenue
0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
3.28% 26.32% 15.57% 5.07%
Earnings before Interest and Taxes (EBIT)
69 5.31 19 93
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
69 5.31 19 93
Valuation Ratios
- - - -
Price to Book Value (P/BV)
10.73 25.50 12.20 13.27
Price to Tangible Book Value (P/TBV)
10.73 25.50 12.20 13.27
Price to Revenue (P/Rev)
4.62 37.67 11.20 3.14
Price to Earnings (P/E)
4.81 54.93 13.48 3.32
Dividend Yield
16.48% 22.72% 3.69% 29.36%
Earnings Yield
20.81% 1.82% 7.42% 30.12%
Enterprise Value to Invested Capital (EV/IC)
46.91 0.00 166.04 221.24
Enterprise Value to Revenue (EV/Rev)
3.96 35.87 10.15 2.12
Enterprise Value to EBITDA (EV/EBITDA)
4.11 52.30 12.22 2.25
Enterprise Value to EBIT (EV/EBIT)
4.11 52.30 12.22 2.25
Enterprise Value to NOPAT (EV/NOPAT)
4.11 52.30 12.22 2.25
Enterprise Value to Operating Cash Flow (EV/OCF)
4.50 20.03 15.88 2.23
Enterprise Value to Free Cash Flow (EV/FCFF)
4.50 20.03 15.41 2.23
Leverage & Solvency
- - - -
Debt to Equity
0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00
Financial Leverage
-0.87 -0.92 -1.03 -0.95
Leverage Ratio
1.63 1.61 1.26 2.90
Compound Leverage Factor
1.63 1.61 1.26 2.90
Debt to Total Capital
0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00
Altman Z-Score
14.80 68.27 31.02 6.64
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - -
Current Ratio
2.33 37.06 4.67 1.30
Quick Ratio
2.26 36.72 4.54 1.29
Cash Flow Metrics
- - - -
Free Cash Flow to Firm (FCFF)
63 14 15 94
Operating Cash Flow to CapEx
0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00
Efficiency Ratios
- - - -
Asset Turnover
1.86 0.23 1.12 1.54
Accounts Receivable Turnover
29.28 3.33 23.05 63.18
Inventory Turnover
0.00 0.00 0.00 0.00
Fixed Asset Turnover
23,819,930.00 2,580,658.00 7,620,676.33 32,865,217.00
Accounts Payable Turnover
0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)
12.47 109.73 15.84 5.78
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
12.47 109.73 15.84 5.78
Capital & Investment Metrics
- - - -
Invested Capital
6.03 -2.53 1.40 0.95
Invested Capital Turnover
23.31 4.43 -40.43 84.13
Increase / (Decrease) in Invested Capital
5.92 -8.56 3.93 -0.45
Enterprise Value (EV)
283 278 232 209
Market Capitalization
330 292 256 310
Book Value per Share
$2.35 $0.87 $1.60 $1.78
Tangible Book Value per Share
$2.35 $0.87 $1.60 $1.78
Total Capital
31 11 21 23
Total Debt
0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00
Net Debt
-48 -14 -24 -100
Capital Expenditures (CapEx)
0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-17 -0.23 -3.01 -77
Debt-free Net Working Capital (DFNWC)
31 14 21 23
Net Working Capital (NWC)
31 14 21 23
Net Nonoperating Expense (NNE)
0.00 0.00 0.00 0.00
Net Nonoperating Obligations (NNO)
-25 -14 -20 -22
Total Depreciation and Amortization (D&A)
0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital to Revenue
-23.70% -2.97% -13.15% -77.97%
Debt-free Net Working Capital to Revenue
43.09% 177.43% 91.75% 23.66%
Net Working Capital to Revenue
43.09% 177.43% 91.75% 23.66%
Earnings Adjustments
- - - -
Adjusted Basic Earnings per Share
$5.24 $0.41 $1.45 $7.11
Adjusted Weighted Average Basic Shares Outstanding
13.12M 13.12M 13.12M 13.12M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding
13.12M 13.12M 13.12M 13.12M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
13.12M 13.12M 13.12M 13.12M
Normalized Net Operating Profit after Tax (NOPAT)
49 4.68 15 68
Normalized NOPAT Margin
69.05% 60.41% 66.00% 68.96%
Pre Tax Income Margin
96.23% 68.58% 83.03% 94.60%
Debt Service Ratios
- - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00
Payout Ratios
- - - -
Dividend Payout Ratio
54.57% 897.06% 24.19% 18.99%
Augmented Payout Ratio
54.57% 897.06% 24.19% 18.99%

Quarterly Metrics And Ratios for Mesabi Trust

This table displays calculated financial ratios and metrics derived from Mesabi Trust's official financial filings.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 7/31/2022 10/31/2022 1/31/2023 4/30/2023 7/31/2023 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-115.74% -99.48% -112.10% -86.98% 326.46% 5,681.78% 386.72% 238.08% -34.37% 1,513.58% 10.04%
EBITDA Growth
-118.15% -102.59% -117.29% -92.47% 289.06% 1,087.71% 255.58% 240.50% -41.22% 1,816.89% 29.34%
EBIT Growth
-118.15% -102.59% -117.29% -92.47% 289.06% 1,087.71% 255.58% 240.50% -41.22% 1,816.89% 29.34%
NOPAT Growth
-112.71% -101.81% -112.10% -92.47% 370.09% 1,511.01% 322.26% 240.50% -41.22% 1,816.89% 29.34%
Net Income Growth
-118.15% -102.59% -117.29% -92.47% 289.06% 1,087.71% 255.58% 240.50% -41.22% 1,816.89% 29.34%
EPS Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Growth
-91.41% -101.41% -102.62% -106.59% 196.37% 2,053.76% 1,151.92% 389.93% -18.12% 1,415.26% 66.28%
Free Cash Flow Firm Growth
-51.35% 1.07% -44.06% -21.21% -10.82% -74.91% -88.13% -80.79% -38.32% 3,337.82% 751.64%
Invested Capital Growth
-99.17% -100.56% -141.95% -109.83% 1,794.09% 3,640.90% 155.26% 297.81% 44.11% 112.68% -32.25%
Revenue Q/Q Growth
-130.76% 101.94% -2,665.09% 185.12% 434.89% -50.49% 27.20% 0.36% 3.83% 1,117.30% -91.33%
EBITDA Q/Q Growth
-135.73% 91.48% -628.81% 133.93% 797.57% -55.51% 14.80% -25.73% 54.94% 1,351.04% -92.25%
EBIT Q/Q Growth
-135.73% 91.48% -628.81% 133.93% 797.57% -55.51% 14.80% -25.73% 54.94% 1,351.04% -92.25%
NOPAT Q/Q Growth
-125.01% 91.48% -628.81% 148.48% 797.57% -55.51% 14.80% -25.73% 54.94% 1,351.04% -92.25%
Net Income Q/Q Growth
-135.73% 91.48% -628.81% 133.93% 797.57% -55.51% 14.80% -25.73% 54.94% 1,351.04% -92.25%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
-88.03% -116.85% -103.65% -60.52% 638.19% 11.05% 9.65% -55.76% 52.00% 1,955.07% -87.97%
Free Cash Flow Firm Q/Q Growth
-19.93% 6.28% -27.13% 27.05% -9.37% -70.10% -65.51% 105.58% 190.94% 1,566.45% -91.46%
Invested Capital Q/Q Growth
-98.49% -152.22% -4,829.87% 74.63% 389.96% -2.37% -23.06% -9.18% 111.24% 44.07% -75.49%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
0.00% -488.53% 0.00% 55.34% 92.86% 83.46% 132.47% 55.74% 83.17% 99.14% 161.52%
EBITDA Margin
0.00% -488.53% 0.00% 55.34% 92.86% 83.46% 75.32% 55.74% 83.17% 99.14% 88.53%
Operating Margin
0.00% -488.53% 0.00% 55.34% 92.86% 83.46% 75.32% 55.74% 83.17% 99.14% 88.53%
EBIT Margin
0.00% -488.53% 0.00% 55.34% 92.86% 83.46% 75.32% 55.74% 83.17% 99.14% 88.53%
Profit (Net Income) Margin
0.00% -488.53% 0.00% 55.34% 92.86% 83.46% 75.32% 55.74% 83.17% 99.14% 88.53%
Tax Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 99.41% 108.37%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.60% 92.28%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% -2,110.58% 0.00% 0.00% 915.25% 1,367.90% 0.00% 4,843.35% 874.25% 3,421.29% 7,448.02%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% -2,109.99% 0.00% 0.00% 915.25% 1,367.90% 0.00% 4,843.35% 874.25% 3,421.29% 7,448.02%
Return on Net Nonoperating Assets (RNNOA)
0.00% 1,734.63% 0.00% 0.00% -866.16% -1,300.08% 0.00% -4,751.58% -783.54% -3,254.49% -7,053.99%
Return on Equity (ROE)
0.00% -375.96% 0.00% -33.62% 49.09% 67.82% 117.13% 91.77% 90.72% 166.80% 394.03%
Cash Return on Invested Capital (CROIC)
904.42% 0.00% 0.00% 0.00% 512.26% 518.20% 1,077.71% 1,539.30% 741.64% 3,164.88% 7,997.66%
Operating Return on Assets (OROA)
0.00% -389.80% 0.00% 0.00% 37.34% 59.22% 84.39% 76.49% 82.45% 153.35% 135.94%
Return on Assets (ROA)
0.00% -389.80% 0.00% 0.00% 37.34% 59.22% 84.39% 76.49% 82.45% 153.35% 135.94%
Return on Common Equity (ROCE)
0.00% -375.96% 0.00% -33.62% 49.09% 67.82% 117.13% 91.77% 90.72% 166.80% 394.03%
Return on Equity Simple (ROE_SIMPLE)
283.67% 178.28% 0.00% -58.28% 31.31% 53.35% 0.00% 103.82% 79.85% 96.41% 0.00%
Net Operating Profit after Tax (NOPAT)
-3.40 -0.29 -2.11 1.02 9.18 4.09 4.69 3.48 5.40 78 6.07
NOPAT Margin
0.00% -341.97% 0.00% 55.34% 92.86% 83.46% 75.32% 55.74% 83.17% 99.14% 88.53%
Net Nonoperating Expense Percent (NNEP)
-6.96% -0.59% -4.67% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - 19.33% - - - 82.17% 26.01%
Cost of Revenue to Revenue
0.00% 588.53% 0.00% 44.66% 7.14% 16.54% -32.47% 44.26% 16.83% 0.86% -61.52%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 57.15% 0.00% 0.00% 0.00% 72.99%
Earnings before Interest and Taxes (EBIT)
-4.86 -0.41 -3.02 1.02 9.18 4.09 4.69 3.48 5.40 78 6.07
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-4.86 -0.41 -3.02 1.02 9.18 4.09 4.69 3.48 5.40 78 6.07
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
23.23 19.52 25.50 23.19 11.12 11.86 12.20 10.21 10.43 3.32 13.27
Price to Tangible Book Value (P/TBV)
23.23 19.52 25.50 23.19 11.12 11.86 12.20 10.21 10.43 3.32 13.27
Price to Revenue (P/Rev)
7.82 10.12 37.67 0.00 24.93 17.33 11.20 7.74 9.67 3.23 3.14
Price to Earnings (P/E)
8.19 10.95 54.93 0.00 35.50 22.23 13.48 9.84 13.06 3.44 3.32
Dividend Yield
19.19% 23.48% 22.72% 22.93% 0.00% 1.83% 3.69% 6.28% 7.45% 5.60% 29.36%
Earnings Yield
12.21% 9.13% 1.82% 0.00% 2.82% 4.50% 7.42% 10.16% 7.66% 29.04% 30.12%
Enterprise Value to Invested Capital (EV/IC)
3,253.87 0.00 0.00 0.00 119.81 125.43 166.04 149.21 77.97 57.10 221.24
Enterprise Value to Revenue (EV/Rev)
7.24 9.60 35.87 0.00 23.09 15.75 10.15 6.94 8.76 2.25 2.12
Enterprise Value to EBITDA (EV/EBITDA)
7.58 10.39 52.30 0.00 32.88 20.20 12.22 8.83 11.84 2.40 2.25
Enterprise Value to EBIT (EV/EBIT)
7.58 10.39 52.30 0.00 32.88 20.20 12.22 8.83 11.84 2.40 2.25
Enterprise Value to NOPAT (EV/NOPAT)
7.58 10.39 52.30 0.00 32.88 20.20 12.22 8.83 11.84 2.40 2.25
Enterprise Value to Operating Cash Flow (EV/OCF)
5.93 7.67 20.03 0.00 74.73 27.09 15.88 10.53 12.20 2.45 2.23
Enterprise Value to Free Cash Flow (EV/FCFF)
5.93 7.67 20.03 132.56 44.43 24.20 15.41 9.69 12.41 2.45 2.23
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.78 -0.82 -0.92 -0.86 -0.95 -0.95 -1.03 -0.98 -0.90 -0.95 -0.95
Leverage Ratio
1.25 1.38 1.61 1.37 1.31 1.15 1.26 1.20 1.10 1.09 2.90
Compound Leverage Factor
1.25 1.38 1.61 1.37 1.31 1.15 1.26 1.20 1.10 1.09 2.67
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
20.21 574.77 66.33 82.06 565.99 32.91 29.25 30.80 36.09 40.22 3.81
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.32 49.82 37.06 67.77 85.41 5.34 4.67 5.61 6.35 18.84 1.30
Quick Ratio
2.30 49.11 36.72 67.25 76.29 5.09 4.54 5.24 5.86 18.68 1.29
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
8.32 8.84 6.45 8.19 7.42 2.22 0.77 1.57 4.58 76 6.52
Operating Cash Flow to CapEx
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.31 0.80 0.23 0.00 0.40 0.71 1.12 1.37 0.99 1.55 1.54
Accounts Receivable Turnover
6.98 6.54 3.33 0.00 10.59 15.07 23.05 16.95 10.85 33.97 63.18
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
14,714,120.33 9,289,611.67 2,580,658.00 0.00 3,216,875.67 4,820,670.67 7,620,676.33 9,087,917.33 7,954,806.67 32,656,731.33 32,865,217.00
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)
52.28 55.83 109.73 0.00 34.46 24.23 15.84 21.53 33.63 10.75 5.78
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
52.28 55.83 109.73 0.00 34.46 24.23 15.84 21.53 33.63 10.75 5.78
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
0.10 -0.05 -2.53 -0.64 1.86 1.82 1.40 1.27 2.68 3.86 0.95
Invested Capital Turnover
7.41 6.17 4.43 0.00 9.86 16.39 -40.43 86.90 10.51 34.51 84.13
Increase / (Decrease) in Invested Capital
-12 -9.13 -8.56 -7.17 1.76 1.87 3.93 1.91 0.82 2.05 -0.45
Enterprise Value (EV)
320 268 278 276 223 228 232 189 209 221 209
Market Capitalization
345 282 292 289 241 251 256 211 231 316 310
Book Value per Share
$1.13 $1.10 $0.87 $0.95 $1.65 $1.61 $1.60 $1.57 $1.69 $7.27 $1.78
Tangible Book Value per Share
$1.13 $1.10 $0.87 $0.95 $1.65 $1.61 $1.60 $1.57 $1.69 $7.27 $1.78
Total Capital
15 14 11 12 22 21 21 21 22 95 23
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-26 -15 -14 -13 -18 -23 -24 -22 -22 -96 -100
Capital Expenditures (CapEx)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-11 -0.05 -0.23 1.28 3.89 -1.77 -3.01 -0.98 0.48 -0.59 -77
Debt-free Net Working Capital (DFNWC)
15 14 14 14 22 21 21 21 22 95 23
Net Working Capital (NWC)
15 14 14 14 22 21 21 21 22 95 23
Net Nonoperating Expense (NNE)
1.46 0.12 0.90 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Obligations (NNO)
-15 -15 -14 -13 -20 -19 -20 -19 -19 -91 -22
Total Depreciation and Amortization (D&A)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital to Revenue
-24.74% -0.18% -2.97% 0.00% 40.35% -12.27% -13.15% -3.58% 2.03% -0.60% -77.97%
Debt-free Net Working Capital to Revenue
33.68% 51.86% 177.43% 0.00% 224.28% 146.17% 91.75% 75.76% 92.67% 97.30% 23.66%
Net Working Capital to Revenue
33.68% 51.86% 177.43% 0.00% 224.28% 146.17% 91.75% 75.76% 92.67% 97.30% 23.66%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.37) ($0.03) ($0.23) $0.08 $0.70 $0.31 $0.36 $0.27 $0.41 $5.97 $0.46
Adjusted Weighted Average Basic Shares Outstanding
13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding
13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M
Normalized Net Operating Profit after Tax (NOPAT)
-3.40 -0.29 -2.11 0.72 6.43 2.86 3.28 2.44 3.78 55 4.25
Normalized NOPAT Margin
0.00% -341.97% 0.00% 38.74% 65.00% 58.42% 52.72% 39.01% 58.22% 69.40% 61.97%
Pre Tax Income Margin
0.00% -488.53% 0.00% 55.34% 92.86% 83.46% 75.32% 55.74% 83.17% 99.74% 81.69%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
133.77% 257.13% 897.06% -339.61% 162.60% 0.00% 24.19% 44.05% 75.04% 18.70% 18.99%
Augmented Payout Ratio
133.77% 257.13% 897.06% -339.61% 162.60% 0.00% 24.19% 44.05% 75.04% 18.70% 18.99%

Financials Breakdown Chart

Key Financial Trends

Mesabi Trust (NYSE: MSB) Financial Performance Summary:

Mesabi Trust has reported fluctuating financial results from Q1 2023 through Q4 2025, demonstrating a significant recovery in profitability after a period of losses in 2022 and early 2023. The quarterly income statements, cash flow statements, and balance sheets reveal insights into revenue trends, profitability, cash flows, and capital structure changes over recent years.

  • Strong turnaround in net income from negative figures in 2022 (e.g., Q2 2022 net loss of -$4.86M) to solid profits in 2024 and 2025, with Q3 2025 showing net income of $78.3M and Q4 2025 $6.07M.
  • Consistent increase in operating revenues from $84681 in Q3 2023 to $79.0M in Q3 2025, indicating growth in core operations.
  • Substantial growth in cash and equivalents with $95.9M reported in Q3 2025, compared to $14.5M in Q3 2023 and $37.9M in Q1 2023, reflecting improved liquidity.
  • Sustained dividend payments per share since 2023, increasing from $0.00 in early 2024 quarters to $0.39 in Q3 2025, providing income to shareholders and reflecting confidence in cash flows.
  • Net cash from operating activities generally positive and growing, e.g., $78.2M in Q3 2025 and $9.4M in Q4 2025, supporting operations without relying heavily on financing.
  • Total operating expenses have been minimal or zero in multiple recent quarters (Q3 2025, Q2 2025), which may warrant closer scrutiny for accuracy or reporting changes.
  • The balance sheet shows very little in plant, property, and equipment (net $3) across all periods, consistent with the company's trust/business model which likely holds mineral rights rather than assets requiring PP&E.
  • Weighted average shares outstanding have remained constant at 13.12 million, indicating no dilution or share buybacks during the periods reported.
  • Negative net income and operating losses persisted through much of 2022 with large quarterly net losses, e.g. -$4.85M in Q2 2022 and -$3.0M in Q4 2023, highlighting prior operational or market challenges.
  • Significant cash outflows due to dividends and financing activities in early periods, notably -$23M dividends in Q1 2023 and -$13.6M in Q2 2023 financing activities, potentially pressuring cash flows before recovery.
  • Volatility in net cash from investing activities, including large purchase and sale of investments in Q2 2023 (~ -$72.5M purchases and $49.2M sales), which may reflect aggressive portfolio adjustments or asset reallocation risk.

Overall Analysis: Mesabi Trust has demonstrated a notable recovery with marked improvements in revenue and net income through 2024 and 2025 after several quarters of losses in 2022 and early 2023. The company exhibits strong liquidity supported by growing cash reserves and stable operating cash flows. However, prior volatility in investments and financing outflows, plus minimal operating expenses disclosure, signal areas for investors to monitor closely. Dividend payments have resumed and grew steadily, which may appeal to income-focused shareholders. The stable share count simplifies EPS analysis.

10/07/25 06:30 PM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Mesabi Trust's Financials

When does Mesabi Trust's financial year end?

According to the most recent income statement we have on file, Mesabi Trust's fiscal year ends in January. Their fiscal year 2025 ended on January 31, 2025.

How has Mesabi Trust's net income changed over the last 3 years?

Mesabi Trust's net income appears to be on an upward trend, with a most recent value of $93.27 million in 2025, rising from $68.77 million in 2022. The previous period was $18.98 million in 2024. See Mesabi Trust's forecast for analyst expectations on what’s next for the company.

What is Mesabi Trust's operating income?
Mesabi Trust's total operating income in 2025 was $93.27 million, based on the following breakdown:
  • Total Gross Profit: $98.28 million
  • Total Operating Expenses: $5.00 million
How has Mesabi Trust's revenue changed over the last 3 years?

Over the last 3 years, Mesabi Trust's total revenue changed from $71.46 million in 2022 to $98.60 million in 2025, a change of 38.0%.

How much debt does Mesabi Trust have?

Mesabi Trust's total liabilities were at $78.40 million at the end of 2025, a 1,271.8% increase from 2024, and a 239.1% increase since 2022.

How much cash does Mesabi Trust have?

In the past 3 years, Mesabi Trust's cash and equivalents has ranged from $13.97 million in 2023 to $100.20 million in 2025, and is currently $100.20 million as of their latest financial filing in 2025.

How has Mesabi Trust's book value per share changed over the last 3 years?

Over the last 3 years, Mesabi Trust's book value per share changed from 2.35 in 2022 to 1.78 in 2025, a change of -24.3%.



This page (NYSE:MSB) was last updated on 10/7/2025 by MarketBeat.com Staff
From Our Partners